CAH
Cardinal Health, Inc.
NYSE · Healthcare · Medical - Distribution · US
$247.18
−0.58%Income statement
| Metric | TTM | 2026 | 2025 | 2025 | 2024 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 254.2B | 254.2B | 63.7B | 222.6B | 226.8B |
| Cost of Revenue | 244.5B | 244.5B | 61.1B | 214.4B | 219.4B |
| Gross Profit | 9.8B | 9.8B | 2.6B | 8.2B | 7.4B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 6.1B | 6.1B | 1.6B | 5.4B | 5.0B |
| General & Admin Expense | — | — | 1.6B | — | — |
| Selling & Marketing Expense | 6.1B | 6.1B | — | 5.4B | 5.0B |
| Other Expenses | 1.0B | 1.0B | 206.0M | 511.0M | 1.2B |
| Total Operating Expenses | 7.2B | 7.2B | 1.8B | 5.9B | 6.2B |
| Cost and Expenses | 251.6B | 251.6B | 62.9B | 220.3B | 225.6B |
| Operating Income (EBIT) | 2.6B | 2.6B | 729.0M | 2.3B | 1.2B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 348.0M | 348.0M | 79.0M | 215.0M | 51.0M |
| Net Interest Income | (348.0M) | (348.0M) | (79.0M) | (215.0M) | (51.0M) |
| Other Non-Op Income/Expense | (439.0M) | (439.0M) | (175.0M) | (174.0M) | (42.0M) |
| Non-Operating Income (excl Interest) | 91.0M | 91.0M | 96.0M | (41.0M) | (9.0M) |
| EBT (Pre-Tax Income) | 2.2B | 2.2B | 554.0M | 2.1B | 1.2B |
| Income Tax Expense | 469.0M | 469.0M | 154.0M | 532.0M | 348.0M |
| Bottom Line | |||||
| Net Income | 1.7B | 1.7B | 398.0M | 1.6B | 852.0M |
| Earnings from Cont. Ops | 1.7B | 1.7B | 400.0M | 1.6B | 853.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 1.7B | 1.7B | 398.0M | 1.6B | 852.0M |
| Per Share | |||||
| Basic EPS | $7.27 | $7.27 | $1.70 | $6.48 | $3.48 |
| Diluted EPS | $7.23 | $7.23 | $1.70 | $6.45 | $3.45 |
| Revenue Per Share | $1,077.32 | $1,077.32 | $272.10 | $923.56 | $925.82 |
| Shares | |||||
| Basic Shares Outstanding | 236.0M | 236.0M | 234.0M | 241.0M | 245.0M |
| Diluted Shares Outstanding | 237.0M | 237.0M | 235.0M | 242.0M | 247.0M |
| Profitability Metrics | |||||
| EBITDA | 3.5B | 3.5B | 754.0M | 3.1B | 2.0B |
| D&A | 956.0M | 956.0M | 121.0M | 790.0M | 710.0M |
| EBIT | 2.5B | 2.5B | 633.0M | 2.3B | 1.3B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026